Top Markets
Coin of the day
Sanofi Sanofi

Sanofi

SNY
Rankning i aktier #179
Sanofi, together with its subsidiaries, engages in the research, development,... Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Aktiekurs
$44.60
Marknadsvärde
$108.62B
Förändring (1 dag)
-1.63%
Förändring (1 år)
-21.62%
Land
FR
Handel Sanofi (SNY)

Kategori

Rörelsemarginal för Sanofi (SNY)
Rörelsemarginal per March 2026 TTM: 25.39%
Enligt de senaste finansiella rapporterna och aktiekursen för Sanofi är företagets nuvarande rörelsemarginal (TTM) 25.39%. Vid slutet av 2024 var rörelsemarginalen 21.47%.
Historik för rörelsemarginal för Sanofi från 2000 till 2026
Rörelsemarginal vid slutet av varje år
År Rörelsemarginal Ändra
2026 (TTM) 25.39% -22.28%
2025 32.67% 52.17%
2024 21.47% 25.48%
2023 17.11% -53.76%
2022 37.00% 78.40%
2021 20.74% -4.11%
2020 21.63% 5.77%
2019 20.45% -41.30%
2018 34.84% 5.10%
2017 33.15% -6.80%
2016 35.57% -2.44%
2015 36.46% -7.58%
2014 39.45% -5.12%
2013 41.58% -4.79%
2012 43.67% 167.09%
2011 16.35% -12.14%
2010 18.61% -10.10%
2009 20.70% -38.90%
2008 33.88% 67.39%
2007 20.24% 4.17%
2006 19.43% -25.64%
2005 26.13% -1,593.14%
2004 -1.75% -104.58%
2003 38.21% 8.89%
2002 35.09% 8.10%
2001 32.46% 22.72%
2000 26.45% 0.00%
Rörelsemarginal för liknande företag eller konkurrenter
Företag Rörelsemarginal Skillnad i rörelsemarginal Land
45.56% -98.21%
US
23.28% -99.08%
GB
27.17% -98.93%
US
26.72% -98.95%
US
31.24% -98.77%
CH
Vad är ett företags Rörelsemarginal?
Rörelsemarginal är en viktig indikator för att bedöma ett företags lönsamhet. Högre Rörelsemarginals är generellt bättre eftersom de visar att ett företag kan sälja sina produkter eller tjänster för betydligt mer än produktionskostnaden. Rörelsemarginal beräknas genom att dividera företagets vinst med dess intäkter.